This filing details a stock transaction by Brent Longnecker, a director at Genprex, Inc. On December 22, 2025, Longnecker acquired 9,000 shares of Common Stock under the Genprex, Inc. 2018 Equity Incentive Plan. These shares will vest on the earlier of August 15, 2026, or the day prior to the company's next annual meet...

Eric Loumeau, Chief Legal Officer of ANAPTYSBIO, INC., reported transactions on December 22, 2025. Loumeau acquired 10,000 shares of Common Stock at $14.02 per share and disposed of 10,000 shares of Common Stock at $51.00 per share. These transactions were executed under a 10b5-1 trading plan. Additionally, Loumeau was...

This filing details a transaction by Michael Lacapria, SVP & Chief Financial Officer of Esquire Financial Holdings, Inc. On December 19, 2025, Lacapria disposed of 180 shares of Common Stock at a price of $107.00 per share, resulting in 16,442 shares owned post-transaction. The filing also lists holdings of vested stoc...

On December 19, 2025, Ladd Delano, EVP, General Counsel of HEALTHEQUITY, INC. (HQY), sold 1500 shares of common stock at a price of $94.72 per share, totaling $142,080. This transaction was executed as part of a Rule 10b5-1 trading plan adopted on June 12, 2025. Following the sale, Mr. Delano directly owns 73,979 share...

On December 19, 2025, Lance Ryan Michael, Chairman and CEO of CONOCOPHILLIPS (COP), reported several transactions involving the company's common stock. Michael acquired 819,900 shares at a price of $33.125 per share, increasing his direct holdings to 826,680 shares. Concurrently, he disposed of 500,708 shares at $92.5 ...

This filing details a transaction by Last Timothy James, EVP, Sales & Marketing at Iridium Communications Inc. On December 19, 2025, Mr. James disposed of 974 shares of Common Stock. The transaction code "F" indicates that the shares were withheld to cover taxes associated with the accelerated vesting of restricted sto...

This filing details transactions made by Lee Yew Hon, the CFO of FingerMotion, Inc. On December 19, 2025, Mr. Hon disposed of 2,000 shares of common stock at a price of $1.50 per share, leaving him with 467,000 shares. Subsequently, on December 22, 2025, he disposed of an additional 6,000 shares of common stock at the ...

This filing reports a transaction by Les Lehner, SVP, Chief Development Officer of Dave & Buster's Entertainment, Inc. (PLAY). On December 22, 2025, Lehner disposed of 993 shares of Common Stock. The transaction code 'F' indicates a stock acquired under a bonus or incentive plan. The reported price per share was $0.00,...

This filing details a transaction involving Teri A. Little, SVP, CLO of APPLIED MATERIALS INC /DE. On December 19, 2025, Ms. Little disposed of 15,472 shares of Common Stock at a price of $256.41 per share. This transaction, marked with code "F", resulted in a post-transaction ownership of 91,949 shares. The shares wit...

James S. Mahan III, CEO of Live Oak Bancshares, Inc., reported a sale of 10,000 shares of Voting Common Stock on December 19, 2025, under a Rule 10b5-1 trading plan. The weighted average sale price was $36.1734, with individual trades ranging from $35.89 to $36.50. Following this transaction, his reported direct or ind...

Vihan Sharma, Chief Revenue Officer of LiveRamp Holdings, Inc., reported a disposition of 1,232 shares of common stock on December 22, 2025. The shares were withheld by the company to cover tax obligations arising from the vesting of restricted stock units. The transaction occurred at a price of $30.19 per share, resul...

Paul F. Lizzul, Chief Medical Officer of ANAPTYSBIO, INC, reported several transactions on December 22, 2025. Lizzul acquired 1,500 shares of Common Stock under the Company's ESPP at a price of $18.5 per share, increasing his post-transaction holdings to 28,467 shares. Concurrently, Lizzul disposed of 1,500 shares of C...

Lord Robert, a director at Integral Ad Science Holding Corp. (IAS), reported a disposition of 29,184 shares of common stock on December 23, 2025, at a price of $10.30 per share. This transaction was executed as part of a merger agreement where the company merged with Igloo Group Parent, Inc. The disposition includes 17...

Cynthia L Lucchese, a director at COOPER COMPANIES, INC. (COO), reported a transaction on December 22, 2025. She acquired 1784 shares of Common Stock at a price of $84.06 per share. Following this transaction, her total ownership of Common Stock is 9445 shares, held directly. The transaction code is "P" for purchase, a...

This filing details a transaction by John David Risher, Chief Executive Officer of Lyft, Inc., involving 327,994 shares of Class A Common Stock. The transaction, dated December 20, 2025, was a disposition code 'D' with a price of $19.42 per share. Following this transaction, Risher holds 11,474,302 shares. A portion of...

This filing details a transaction by Lyssikatos Joseph P, Chief Scientific Officer of Enliven Therapeutics, Inc. On December 19, 2025, Mr. Lyssikatos sold 5,000 shares of Common Stock at a weighted average price of $16.8412 per share, pursuant to a Rule 10b5-1 trading plan. This sale was executed through multiple trade...

James S. Mahan III, CEO of Live Oak Bancshares, Inc., reported a sale of 10,000 shares of Voting Common Stock on December 19, 2025, under a Rule 10b5-1 trading plan. The weighted average sale price was $36.1734, with individual trades ranging from $35.89 to $36.50. Following this transaction, his reported direct or ind...

On December 22, 2025, Stan Smith, a director at MAIA Biotechnology, Inc. (MAIA), acquired 57,189 shares of common stock through a Securities Purchase Agreement, executed under the Issuer's 2021 Equity Incentive Plan. The shares were purchased at a price of $1.224 per share, resulting in a post-transaction ownership of ...

Susanne Meline, a director at MDB Capital Holdings, LLC, reported a transaction on August 14, 2025. She acquired 10,000 shares of Common Stock at a price of $3.4 per share, increasing her post-transaction holdings to 30,000 shares. Additionally, she acquired 10,000 Restricted Stock Units (RSUs) with an exercise price o...

Roberto Mignone, a director at Guardant Health, Inc., reported a disposition of 264 shares of Common Stock on December 21, 2025. The transaction code "M" indicates a grant, and the disposition code "D" suggests these shares were part of a Restricted Stock Unit (RSU) award. The RSUs were granted on November 8, 2024, and...

On December 22, 2025, THOMAS M. MONTGOMERY, SR. VP. - COMPTROLLER of AMETEK INC/ reported transactions involving the company's Common Stock and Stock Options. Montgomery acquired 6,388 shares of Common Stock at a price of $85.45 per share under a SARs plan, increasing his post-transaction holdings to 28,504 shares. In ...

Dennis Mulroy, Chief Financial Officer of ANAPTYSBIO, INC, reported transactions on December 22, 2025. Mulroy acquired 10,000 shares of common stock at $20.16 per share and disposed of 10,000 shares of common stock at $50.00 per share. These transactions were executed under a Rule 10b5-1 trading plan. Additionally, Mul...

This filing details transactions by Mac Ban Ryan Norris, Chief Revenue Officer of Confluent, Inc. On December 22, 2025, Norris sold 1,218 shares of Class A Common Stock at $29.96 per share, resulting in 335,732 shares remaining. On December 23, 2025, an additional 3,053 shares were sold at the same price, leaving 332,6...

David Eugene Maher, President and CEO of Acushnet Holdings Corp. (GOLF), reported a transaction on December 19, 2025. Maher acquired 2234.93 shares of Common Stock at a price of $82.45 per share. This acquisition was part of dividend equivalent rights related to restricted and performance stock units under the company'...

Jennifer H. Mak, Chief Accounting Officer of Axon Enterprise, Inc., reported a sale of 1134 shares of common stock on December 19, 2025. The transaction was executed at a price of $600 per share, totaling $680,400. Following this transaction, Ms. Mak owns 13739.824 shares of common stock. This sale was conducted under ...